Zhang Yan-hui, Yang Qing, Cui Wei, Liu Yan-xue, Liu Su-xiang, Yao Xin
Department of Genitourinary Surgery, Tianjin Cancer Hospital, China.
Zhonghua Zhong Liu Za Zhi. 2010 Feb;32(2):117-22.
The aim of this study was to evaluate the expressions of CD34, CD31 and microvessel density (MVD) in different subtypes of renal cell carcinoma (RCC) as well as the relationship between MVD and clinicopathological factors.
Expressions of CD31 and CD34 were detected in 149 patients with RCC using SP immunohistochemical staining. The MVD was studied by Weidner's method.
The expressions of CD31 and CD34 in the clear cell renal cell carcinoma (CCRCC) (98.35 +/- 55.05, 128.04 +/- 46.44) were significantly higher than those in chromophobe renal cell carcinoma (ChRCC) (30.70 +/- 17.72, 48.55 +/- 14.09) and papillary renal cell carcinoma (PRCC) (21.60 +/- 9.38, 38.12 +/- 10.98) (P < 0.01). The MVD value marked by CD31 (30.70 +/- 17.72, 21.60 +/- 9.38) was much lower than that marked by CD34 (48.55 +/- 14.09, 38.12 +/- 10.98) between ChRCC and PRCC (P < 0.01). Smaller and immatured microvessels and even single endothelial cells could be clearly seen. The MVD values marked by CD31 and CD34 were negatively correlated with the pathological grades (r(CD34) = -0.618, P < 0.01; r(CD31) = -0.442, P < 0.01) and clinical stages (r(CD34) = -0.283, P < 0.05; r(CD31) = -0.256, P < 0.05) in CCRCC. But no association was found in non-CCRCC (P > 0.05).
MVD is significantly correlated with different types of endothelial labeling. The microvascular endothelial cells could be shown clearly by its related antigen labeling such as CD34 and CD31. CD34 is more sensitive than CD31. The MVD of CCRCC is significantly higher than that in non-CCRCC. The expressions of CD31 and CD34 are not correlated with tumor grade and stage in ChRCC and PRCC, while there is a negative correlation in CCRCC.
本研究旨在评估肾细胞癌(RCC)不同亚型中CD34、CD31的表达及微血管密度(MVD),以及MVD与临床病理因素之间的关系。
采用SP免疫组织化学染色法检测149例RCC患者中CD31和CD34的表达。采用Weidner法研究MVD。
透明细胞肾细胞癌(CCRCC)中CD31和CD34的表达(98.35±55.05,128.04±46.44)显著高于嫌色细胞肾细胞癌(ChRCC)(30.70±17.72,48.55±14.09)和乳头状肾细胞癌(PRCC)(21.60±9.38,38.12±10.98)(P<0.01)。ChRCC和PRCC之间,CD31标记的MVD值(30.70±17.72,21.60±9.38)远低于CD34标记的MVD值(48.55±14.09,38.12±10.98)(P<0.01)。可见较小且未成熟的微血管,甚至单个内皮细胞。CCRCC中CD31和CD34标记的MVD值与病理分级(r(CD34)=-0.618,P<0.01;r(CD31)=-0.442,P<0.01)和临床分期(r(CD34)=-0.283,P<0.05;r(CD31)=-0.256,P<0.05)呈负相关。但在非CCRCC中未发现相关性(P>0.05)。
MVD与不同类型的内皮标记物显著相关。通过CD34和CD31等相关抗原标记可清晰显示微血管内皮细胞。CD34比CD31更敏感。CCRCC的MVD显著高于非CCRCC。ChRCC和PRCC中CD31和CD34的表达与肿瘤分级和分期无关,而在CCRCC中呈负相关。